Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
17.16
-0.39 (-2.22%)
Dec 20, 2024, 4:00 PM EST - Market closed
Centessa Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 2,262 | 777 | 293 | 1,012 | - | - |
| Market Cap Growth | 226.22% | 165.01% | -71.03% | - | - | - |
| Enterprise Value | 1,829 | 579 | -83 | 433 | - | - |
| Last Close Price | 17.16 | 7.96 | 3.10 | 11.26 | - | - |
| PS Ratio | 265.21 | 113.40 | - | - | - | - |
| PB Ratio | 4.53 | 3.29 | 0.87 | 2.06 | - | - |
| P/TBV Ratio | 4.12 | 3.29 | 0.87 | 2.06 | - | - |
| EV/Sales Ratio | 266.85 | 84.53 | - | - | - | - |
| Debt / Equity Ratio | 0.17 | 0.36 | 0.21 | 0.15 | 1.82 | - |
| Asset Turnover | 0.01 | 0.02 | - | - | - | - |
| Quick Ratio | 21.15 | 7.51 | 10.96 | 24.84 | 1.18 | - |
| Current Ratio | 21.52 | 8.00 | 11.42 | 25.52 | 1.30 | - |
| Return on Equity (ROE) | -42.52% | -52.79% | -52.24% | -154.41% | - | - |
| Return on Assets (ROA) | -20.47% | -26.61% | -24.48% | -27.16% | - | - |
| Return on Capital (ROIC) | -21.80% | -29.44% | -27.01% | -30.24% | - | - |
| Earnings Yield | -7.13% | -19.44% | -73.73% | -37.73% | - | - |
| FCF Yield | -5.76% | -20.65% | -68.78% | -13.47% | - | - |
| Buyback Yield / Dilution | -11.08% | -2.97% | -24.26% | -401.11% | - | - |
| Total Shareholder Return | -11.08% | -2.97% | -24.26% | -401.11% | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.